FOX News Digital Finishes October as Top-Performing News Brand in Multiplatform Minutes and Views
FOX News Marks 98th Consecutive Month as the Most-Engaged News Organization on Social Media FOX…
Month: November 2022
Field Service Costs Rose Sharply in 2022 Despite Overall Service Improvements
While key performance indicators improved across service teams, average costs for field service rose 7%…
Ventas Recognized for Industry ESG Leadership in 2022
Company Receives Nareit “Leader in the Light” Award for Sixth Consecutive Year and Earns Bronze…
SORACOM Applies for Listing on the Tokyo Stock Exchange
TOKYO–(BUSINESS WIRE)–KDDI CORPORATION and SORACOM, INC, a global provider of advanced IoT connectivity services, today…
Verta Continues Strong Momentum with Growing Demand for Its Operational AI Platform and Launch of Next-Generation Model Management System for AI-Driven Enterprises
PALO ALTO, Calif.–(BUSINESS WIRE)–#ai–Verta, the Operational AI company, today announced strong momentum with continued adoption…
Harris Williams Advises Bregal in Connection with the Combination of Four Portfolio Companies to Form GENII Software Group
LONDON–(BUSINESS WIRE)–Harris Williams, a global investment bank specializing in M&A advisory services, announces it advised…
Bento Engine Launches Children & Wealth Program to Educate the Next Generation
New program provides actionable, age-based financial guidance and activities to help parents teach their children…
Palisade Bio Appoints Herbert B. Slade, MD, FAAAAI as Chief Medical Officer
Established academic and corporate executive with proven track record leading large, multinational organizations across the…
TrueBinding Announces Results of TB006 Phase 1b/2 Placebo Controlled Proof-of-Concept Trial Showing Improvement on the Primary Cognition and Function Endpoint in Patients with Mild to Severe Alzheimer’s Disease
Top line data from a one-month TB006 treatment regimen shows improvements in Clinical Dementia Rating-Sum…
AmMax Bio Announces Oral Presentation of Phase 2 Data of AMB-05X for the Treatment of Tenosynovial Giant Cell Tumor (TGCT) at the 2022 CTOS Annual Meeting
Using local administration for a local disease, positive clinical results suggest AMB-05X could become best-in-class…
Belite Bio Finalizes Phase 3 Clinical Trial Plans for Advanced Dry AMD Treatment with Tinlarebant (LBS-008)
Tinlarebant (a/k/a LBS-008) is Belite Bio’s orally administered tablet intended as an early intervention to…
TFF Pharmaceuticals Prices $10.675 Million Offering of Common Stock and Warrants
FORT WORTH, Texas, Nov. 18, 2022 (GLOBE NEWSWIRE) — TFF Pharmaceuticals, Inc. (NASDAQ: TFFP), a…
TeraImmune Presented Research on TREGable™ Technology at HCA Asia 2022
GERMANTOWN, Md., Nov. 18, 2022 (GLOBE NEWSWIRE) — TeraImmune, Inc., a biotechnology company focused on…
VYNE Therapeutics to Present at Piper Sandler 34th Annual Healthcare Conference
BRIDGEWATER, N.J., Nov. 18, 2022 (GLOBE NEWSWIRE) — VYNE Therapeutics Inc. (Nasdaq: VYNE) (“VYNE” or…
Rain Therapeutics to Participate in Piper Sandler’s 34th Annual Healthcare Conference
NEWARK, Calif., Nov. 18, 2022 (GLOBE NEWSWIRE) — Rain Therapeutics Inc. (NasdaqGS: RAIN), (“Rain”), a…
Oncorus Presents Preclinical Data Supporting ONCR-719, an armed HSV-1 Vector engineered to use the Epidermal Growth Factor Receptor (EGFR/EGFRvIII) for viral entry in Glioblastoma, at the 2022 Society for Neuro-Oncology Annual Meeting
ONCR-719 is uniquely engineered to use the Epidermal Growth Factor Receptor (EGFR/EGFRvIII) for viral entry,…
InMed Pharmaceuticals Announces $6 Million Private Placement Priced at a Premium to Market
VANCOUVER, British Columbia, Nov. 18, 2022 (GLOBE NEWSWIRE) — InMed Pharmaceuticals Inc. (“InMed” or the…
Candel Therapeutics Announces Oral Presentation of Updated Data from its Phase 1 Clinical Trial of CAN-3110 in 41 Patients with Recurrent High-Grade Glioma at the Society for Neuro-Oncology 27th Annual Meeting
CAN-3110 designed to limit replication and promote anti-tumor response to tumor cells while protecting healthy…
Tilray Launches ‘Take Back Control’ Platform to Provide Women With Free Medical Cannabis Resources
LEAMINGTON, Ontario, Nov. 18, 2022 (GLOBE NEWSWIRE) — Tilray Brands, Inc. (“Tilray” or the “Company”)…
Apellis Announces FDA Acceptance of NDA Amendment and New PDUFA Date of February 26, 2023 for Pegcetacoplan for Geographic Atrophy (GA)
WALTHAM, Mass., Nov. 18, 2022 (GLOBE NEWSWIRE) — Apellis Pharmaceuticals, Inc. (Nasdaq: APLS), a global…